Frontlight ResearchEarly access
Ovarian cancer trials in United States
348 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleWhole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation and a Predictor of Treatment Response in Ovarian Cancer
- Where
- Knoxville
- Age
- 18 years and over
- People
- 50
- Run by
- University of Tennessee Graduate School of Medicine
See details and how to joinNCT07764133 - Phase 2Taking peoplePembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer
- Where
- Buffalo, Houston
- Age
- 18 years and over
- People
- 80
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT05231122 - Phase 1/2Taking peopleStudy to Assess GTAEXS617 in Participants With Advanced Solid Tumors
- Where
- Columbus, Grand Rapids, Los Angeles, New York, San Antonio, West Valley City
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
See details and how to joinNCT05985655 - Phase 1/2Taking peopleSacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
- Where
- New York
- Age
- 18 years and over
- People
- 54
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT06040970 - Phase 1Taking peoplePhase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors
- Where
- Fort Worth, Lake Success, New York, The Bronx
- Age
- 18 years and over
- People
- 90
- Run by
- Xencor, Inc.
See details and how to joinNCT07593092 - No phaseTaking peopleData Collection for Patients With Low Grade Ovarian or Peritoneal Tumors
- Where
- Houston
- People
- 2,000
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT00488878 - Phase 1/2Taking peopleA Study of DM002 in Patients With Advanced Solid Tumors
- Where
- Houston, Huntersville, Oklahoma City, San Francisco
- Age
- 18 years and over
- People
- 280 worldwide
- Run by
- Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
See details and how to joinNCT06751329 - No phaseTaking peopleFasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer
- Where
- Cleveland
- Age
- 18 years and over
- People
- 20
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT06386887 - Phase 4Taking peopleStudy Evaluating Safety, Tolerability, and Metabolism of Niraparib
- Where
- Fort Lauderdale, Jacksonville, Miami
- Age
- 18 years and over
- People
- 70 worldwide
- Run by
- University of Miami
See details and how to joinNCT06412120 - Phase 1Taking peopleIDOV-Immune for Advanced Solid Tumors
- Where
- Houston, San Antonio, St Louis
- Age
- 18 years and over
- People
- 78 worldwide
- Run by
- ViroMissile, Inc.
See details and how to joinNCT06910657 - Phase 1Taking peopleStudy Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
- Where
- Austin, Buffalo, Cleveland, Fairfax, Grand Rapids, Hackensack, Houston, Little Rock, Los Angeles, Peoria, San Antonio, Seattle
- Age
- 18 years and over
- People
- 226
- Run by
- Whitehawk Therapeutics, Inc.
See details and how to joinNCT07444814 - No phaseTaking peopleClinical Pre-screening Protocol for Ovarian Cancer
- Where
- Albuquerque, Atlanta, Lubbock, New York, Oklahoma City, Seattle, Tampa
- Age
- 18 years and over
- People
- 60 worldwide
- Run by
- Allarity Therapeutics
See details and how to joinNCT03877796 - No phaseTaking peopleThe DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons
- Where
- Birmingham
- Age
- 18 years to 99 years
- People
- 1,700
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT03538665 - No phaseTaking peopleComprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 55
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06545604 - No phaseNot yet taking people in United StatesAnalysis of Breath Volatile Organic Compounds Using Mass Spectrometry
- Where
- Oklahoma City
- Age
- 18 years and over
- People
- 2,000
- Run by
- University of Oklahoma
See details and how to joinNCT07732686 - Phase 2Taking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Baltimore, Beverly Hills, Boston, Colombus, Columbus, Dallas, Duluth, Houston, Maumee, Miami, Morgantown, Nashville, New York, Norwalk, Omaha, Philadelphia, Providence, Rockville, Saint Joseph, San Francisco, Seattle, Summit, Temple, Toledo, Westwood, Los Angeles, Winston-Salem
- Age
- 8 years and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - Phase 1Taking peopleCirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer
- Where
- Aurora
- Age
- 18 years and over
- People
- 50
- Run by
- University of Colorado, Denver
See details and how to joinNCT06856499 - Phase 1Taking peopleStudy of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Where
- Fairfax, Goodyear, La Jolla, Lake Mary, Myrtle Beach, Nashville, New York, Philadelphia, San Antonio, San Francisco, St Louis
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- MOMA Therapeutics
See details and how to joinNCT06545942 - Phase 2Not yet taking people in United StatesStudy of Autologous, Metabolically Optimized, CD137+ Tumor-Infiltrating Lymphocytes Followed by Consolidative Oral Cyclophosphamide, Bevacizumab, and Pembrolizumab
- Where
- Charleston
- Age
- 18 years to 80 years
- People
- 20
- Run by
- Medical University of South Carolina
See details and how to joinNCT07720180 - Phase 3Taking peopleAZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Where
- Billings, Birmingham, Blue Ash, Burlington, Camden, Chapel Hill, Chicago, Dayton, Evanston, Fairfax, Fort Lauderdale, Fort Wayne, Gainesville, Germantown, Indianapolis, Jupiter, La Jolla, Las Vegas, Lebanon, Little Rock, Louisville, Miami, Minneapolis, Omaha, Peoria, Portland, Roanoke, Salt Lake City, San Antonio, Seattle, Springfield, Sylvania, The Bronx, Towson, Tyler, Urbana, Washington D.C., Weston, Worcester, York
- Age
- 18 years and over
- People
- 1,100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07218809 · EU 2025-520466-22-00 - No phaseTaking peopleTrial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer
- Where
- Miami, New Haven
- Age
- 18 years and over
- People
- 200
- Run by
- Yale University
See details and how to joinNCT05761561 - Phase 1Taking peopleA Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
- Where
- Columbus, Dallas, Hackensack, Houston, Los Angeles
- Age
- 18 years and over
- People
- 240 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06476808 · EU 2025-523067-38-01 - Phase 2Taking peopleAbemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
- Where
- Los Angeles
- People
- 32
- Run by
- Jonsson Comprehensive Cancer Center
See details and how to joinNCT04469764 - Phase 1/2Taking peopleEffect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
- Where
- Orange
- Age
- 18 years and over
- People
- 102
- Run by
- University of California, Irvine
See details and how to joinNCT04520139 - Phase 1/2Taking peopleTrial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
- Where
- Orange
- Age
- 18 years and over
- People
- 67
- Run by
- University of California, Irvine
See details and how to joinNCT07064018